Justin Stebbing: Amazing work to identify PANK4 as a major factor in resistance to routine treatment in one of the hardest-to-treat tumors, glioblastoma
Justin Stebbing shared on LinkedIn:
“Huge congratulations to an amazing team led by Georgios Giamas, for producing amazing work to identify PANK4 as being a major factor in resistance to routine treatment in one of the hardest-to-treat tumors, glioblastoma. Really lucky to be included here and the science is exceptional.”
Read further.
Source: Justin Stebbing/LinkedIn
Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London, and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is editor-in-chief of Nature’s cancer journal Oncogene.
Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023